AL002-005.xlsx

syn26475799

Created By Ashley Cannon ashleycannon

Id: 663d3c9a-3a57-4914-8bb6-a5ad9fce389b
Assay: in vivo tumor growth
assay: in vivo tumor growth
Species: Homo sapiens
StudyId: syn8012530
species: Homo sapiens
studyId: syn8012530
BodyPart: back
DataType: clinical
EntityId: syn26475799
InChIKey: CYOHGALHFOKKQC-UHFFFAOYSA-N
bodyPart: back
dataType: clinical
entityId: syn26475799
Component: ClinicalAssayTemplate
Diagnosis: Neurofibromatosis type 1
StudyName: Neurofibromatosis Type 1 Dermal Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial
TumorType: Cutaneous Neurofibroma
diagnosis: Neurofibromatosis type 1
studyName: Neurofibromatosis Type 1 Cutaneous Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial
tumorType: Cutaneous Neurofibroma
FileFormat: excel
Initiative: Francis S. Collins Scholars Program
accessType: Public Access
fileFormat: excel
initiative: Francis S. Collins Scholars Program
DataSubtype: raw
dataSubtype: raw
CompoundName: Selumetinib
IndividualID: AL002-005
ResourceType: experimentalData
compoundName: Selumetinib
individualID: AL002-005
resourceType: experimentalData
FundingAgency: NTAP
TimePointUnit: months
fundingAgency: NTAP
timePointUnit: months
ExperimentalTimepoint: 0;4;8;12;16;20;24
experimentalTimepoint: 0;4;8;12;16;20;24

AL002-005.xlsx page is loading…